Solid phase oligonucleotide synthesis using phospholane intermediates

• US 5,512,668 A
• Filed: 01/23/1992
• Issued: 04/30/1996
• Est. Priority Date: 03/06/1991
• Status: Expired due to Term

• Current Assignee: Polish Academy of Sciences (Government of Poland)
• Original Assignee: Polish Academy of Sciences (Government of Poland)
• Inventors: Stec, Wojciech J., Grajkowski, Andrzej, Uznanski, Bogdan
• Primary Examiner(s): Rollins, John W.
• Assistant Examiner(s): CRANE, LAWRENCE E
• Application Number:
  US07/826,929
• Time in Patent Office: 1,559 Days
• Field of Search: 536/25.33, 536/25.4, 536/26.71, 536/26.80.26.90
• US Class Current: 536/25.33
• CPC Class Codes: C07F 9/6564 having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
• CPC Class Codes: C07F 9/6578 having phosphorus and sulfur atoms with or without oxygen atoms, as ring hetero atoms
• CPC Class Codes: C07H 19/10 with the saccharide radical esterified by phosphoric or polyphosphoric acids
• CPC Class Codes: C07H 19/20 with the saccharide radical esterified by phosphoric or polyphosphoric acids
• CPC Class Codes: C07H 21/00 Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Abstract

Methods and compounds are provided for solid phase synthesis of oligonucleotides and related polymers by condensing protected monomer-O- 1,3,2-dichalcogen-substituted-phospholane! synthons in the presence of a catalytic base. Compounds of the invention include 2-N-substituted-1,3,2-dichalcogen-substituted-phospholane precursors of the above synthons, the protected monomer-O- 1,3,2-dichalcogen-substituted-phospholane! synthons, and P-chiral oligonucleotides and related P-chiral polymers.

Claims

1. A method of synthesizing a polymer of a predetermined length, the polymer having a plurality of phosphorus linkages, the phosphorus linkages being R_p chiral, S_p chiral, or achiral, and the polymer having the formula:

##STR9## wherein;

Q is an alkyl or alkenyl having from 1 to 8 carbon atoms;

an alkyloxy or alkylthio having from 1 to 8 carbon atoms and from 1 to 2 heteroatoms;

or when taken together with both adjacent oxygens, is a nucleoside or a nucleoside analog;

R¹ is hydrogen or a hydroxyl protecting group;

n is in the range of from 1 to 200, inclusive;

X is S, O, or Se, or a substituted imino of the form ═

NR² wherein R² is alkyl having from 1 to 6 carbon atoms or aryl, alkyl-substituted aryl, or alkenyl-substituted aryl having from 6 to 12 carbon atoms; and

Y is S, O, or Se;

the method comprising the steps of;

(a) providing a first monomer attached to a solid phase support, the first monomer having a protected hydroxyl;

(b) deprotecting the protected hydroxyl to form a free hydroxyl;

(c) reacting with the free hydroxyl a synthon selected from the group defined by the formula;

##STR10## wherein;

Z is S or Se;

Q, R¹, X, and Y are defined as above, and R³, R⁴, R⁵, and R⁶ are separately hydrogen or alkyl having from 1 to 4 carbon atoms or are separately or together with the carbon atoms to which they are attached aryl or alkyl-substituted aryl having from 6 to 12 carbon atoms; and

(d) repeating steps (b) and (c) until the predetermined length of the polymer is achieved.

2. The method of claim 1 wherein said step of reacting includes reacting in the presence of a catalytic base.

3. The method of claim 2 further including the step of capping unreacted free hydroxyls after said step (c).

4. The method of claim 3 wherein:

Z is S;

Q is alkyl or alkenyl having from 3 to 6 carbon atoms, or alkoxy having from 3 to 6 carbon atoms and one oxygen atom, or when taken together with both adjacent oxygens, is a nucleoside or a nucleoside analog; and

n is in the range of 12 to 60, inclusive.

5. The method of claim 4 wherein Q is a nucleoside or a nucleoside analog.

6. The method of claim 5 wherein said polymer is an oligonucleotide and said synthon is selected from the group defined by the formula:

##STR11## wherein B is a purine or a pyrimidine;

wherein D'"'"' is hydrogen, hydroxyl, or --OR" such that R" is a 3'"'"'-hydroxyl protecting group; and

wherein D is hydrogen, halogen, hydroxyl, or --OR'"'"', such that R'"'"' is alkyl having from 1 to 3 carbon atoms or a 2'"'"'-hydroxyl protecting group.

7. The method of claim 6 wherein said synthon is selected from the group defined by the formula:

##STR12##

8. The method of claim 7 wherein D is hydrogen.

9. The method of claim 8 wherein X is O or S and wherein Y is O or S.

10. The method of claim 9 wherein X is O or S and Y is O or S and wherein at least one of X or Y is O and at least one of X or Y is S.

11. The method of claim 10 wherein n is in the range of 15 to 30, inclusive.

12. The method of claim 11 wherein said catalytic base is 1,8-diazabicyclo 5.4.0!undec-7-ene.

13. The method of claim 2 wherein one or more of said phosphorus linkages of said polymer are each either R_p or S_p chiral, and the positions and chiralities of the one or more R_p or S_p chiral phosphorus linkages are predetermined.

14. The method of claim 13 further including the step of capping unreacted free hydroxyls after said step (c).

15. The method of claim 14 wherein:

Q is alkyl or alkenyl having from 3 to 6 carbon atoms, or alkoxy having from 3 to 6 carbon atoms and one oxygen atom, or when taken together with both adjacent oxygens, is a nucleoside or a nucleoside analog; and

n is in the range of 12 to 60, inclusive.

16. The method of claim 15 wherein Q is a nucleoside or a nucleoside analog.

17. The method of claim 16 wherein said polymer is an oligonucleotide and said synthon is selected from the group defined by the formula:

##STR13## wherein B is a purine or a pyrimidine and wherein D is hydrogen, halogen, hydroxyl, or --OR'"'"', wherein R'"'"' is alkyl having from 1 to 3 carbon atoms or a 2'"'"'-hydroxyl protecting group.

18. The method of claim 17 wherein said synthon is selected from the group defined by the formula:

##STR14##

19. The method of claim 18 wherein D is hydrogen.

20. The method of claim 19 wherein X is O or S and wherein Y is O or S.

21. The method of claim 20 wherein X is O or S and Y is O or S and wherein at least one of X or Y is O and at least one of X or Y is S.

22. The method of claim 21 wherein n is in the range of 15 to 30, inclusive.

23. The method of claim 22 wherein said catalytic base is 1,8-diazabicyclo 5.4.0!undec-7-ene.

24. A method of synthesizing a P-chiral oligonucleotide of a predetermined P-chirality and length less than 200 monomers, the P-chiral oligonucleotide having a plurality of linkages selected from the group consisting of phosphorothioate, phosphorodithioate, phosphoroselenoate. phosphorodiselenoate, phosphoroanilothiolate, phosphoroanilidate, and phosphodiester, the phosphorothioate, phosphoroselenoate, phosphoroanilothiolate, and phosphoroanilidate linkages being R_p chiral or S_p chiral, the method comprising the steps of:

(a) providing a first nucleoside or nucleoside analog attached to a solid phase support, the first nucleoside or nucleoside analog having a protected hydroxyl;

(b) deprotecting the protected hydroxyl to form a free hydroxyl;

(c) reacting with the free hydroxyl a synthon selected from the group defined by the formula;

##STR15## wherein;

B is purine or pyrimidine;

D'"'"' is hydrogen, hydroxyl, or --OR" such that R" is a 3'"'"'-hydroxyl protecting group;

D is hydrogen, halogen, hydroxyl or --OR'"'"', such that R'"'"' is an alkyl having from 1 to 3 carbon atoms or a 2'"'"'-hydroxyl protecting group;

X is S, O, or Se, or a substituted imino of the form ═

NR² wherein R² is alkyl having from 1 to 6 carbon atoms or aryl, alkyl-substituted aryl, or alkenyl-substituted aryl having from 6 to 12 carbon atoms;

Y is S, O, or Se;

Z is S or Se;

R¹ is a hydroxyl protecting group; and

R³, R⁴, R⁵, and R⁶ are separately hydrogen or alkyl having from 1 to 4 carbon atoms or are separately or together with the carbon atoms to which they are attached aryl or alkyl-subsituted aryl having from 6 to 12 carbon atoms; and

(d) repeating steps (b) and (c) until the the P-chiral oligonucleotide of predetermined P-chirality and length is obtained.

25. The method of claim 24 wherein said step of reacting includes reacting in the presence of a catalytic base.

26. The method of claim 25 further including the step of capping unreacted free hydroxyls after said step (c).

27. The method of claim 26 wherein said synthon is selected from the group defined by the formula:

##STR16## wherein;

B is a purine or a pyrimidine;

D is hydrogen, halogen, hydroxyl, or --OR'"'"', such that R'"'"' is alkyl having from 1 to 3 carbon atoms or a 2'"'"'-hydroxyl protecting group;

R³, R⁴, R⁵, and R⁶ are separately hydrogen or methyl;

X is S or O;

Y is S or O; and

Z is S.

28. The method of claim 27 wherein R³, R⁴, R⁵, and R⁶ are separately hydrogen or methyl.

29. The method of claim 28 wherein said P-chiral oligonucleotide has a plurality of linkages selected from the group consisting of phosphorothioate and phosphodiester, the phosphorothioate linkages being R_p chiral or S_p chiral, and wherein X is S or O and Y is S or O, such that at least one X or Y in said P-chiral oligonucleotide is S.

30. The method of claim 29 wherein said predetermined length of said P-chiral oligonucleotide is in the range of 12 to 60 monomers.

31. The method of claim 30 wherein said catalytic base is 1,8-diazabicyclo 5.4.0!undec-7-ene.